Publications

Lyden, Patrick D, et al. “Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation.”. Front Neurol, vol. 12, Jan. 2021, p. 593582, https://doi.org/10.3389/fneur.2021.593582.

Zhang, Hong, et al. “The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area.”. Front Pharmacol, vol. 12, Jan. 2021, p. 632757, https://doi.org/10.3389/fphar.2021.632757.

Smith, Angela F, et al. “Haploinsufficiency of Tau Decreases Survival of the Mouse Model of Niemann-Pick Disease Type C1 But Does Not Alter Tau Phosphorylation.”. J Appl Genet, vol. 61, no. 4, Dec. 2020, pp. 567-70, https://doi.org/10.1007/s13353-020-00572-6.

Ronaldson, Patrick T, and Davis, Thomas P. “Regulation of Blood-Brain Barrier Integrity by Microglia in Health and Disease: A Therapeutic Opportunity.”. J Cereb Blood Flow Metab, vol. 40, no. 1_suppl, Dec. 2020, pp. S6-S24, https://doi.org/10.1177/0271678X20951995.

Stack, Shobha W, et al. “Childbearing Decisions in Residency: A Multicenter Survey of Female Residents.”. Acad Med, vol. 95, no. 10, Oct. 2020, pp. 1550-7, https://doi.org/10.1097/ACM.0000000000003549.

Duron, David I, et al. “Daily Intermittent Fasting in Mice Enhances Morphine-Induced Antinociception While Mitigating Reward, Tolerance, and Constipation.”. Pain, vol. 161, no. 10, Oct. 2020, pp. 2353-6, https://doi.org/10.1097/j.pain.0000000000001918.

Stine, Carrie, et al. “Heat Shock Protein 90 Inhibitors Block the Antinociceptive Effects of Opioids in Mouse Chemotherapy-Induced Neuropathy and Cancer Bone Pain Models.”. Pain, vol. 161, no. 8, Aug. 2020, pp. 1798-07, https://doi.org/10.1097/j.pain.0000000000001886.

LaVigne, Justin, et al. “The Endomorphin-1 2 and Dynorphin-B Peptides Display Biased Agonism at the Mu Opioid Receptor.”. Pharmacol Rep, vol. 72, no. 2, Apr. 2020, pp. 465-71, https://doi.org/10.1007/s43440-020-00061-x.

Mukhopadhyay, Himadri, and Lee, Nam Y. “Multifaceted Roles of TAK1 Signaling in Cancer.”. Oncogene, vol. 39, no. 7, Feb. 2020, pp. 1402-13, https://doi.org/10.1038/s41388-019-1088-8.

Lei, Wei, et al. “A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.”. J Pain, vol. 21, no. 1-2, Jan. 2020, pp. 146-60, https://doi.org/10.1016/j.jpain.2019.05.017.

Doyle, Timothy M, et al. “Activation of Sphingosine-1-Phosphate Receptor Subtype 1 in the Central Nervous System Contributes to Morphine-Induced Hyperalgesia and Antinociceptive Tolerance in Rodents.”. Pain, vol. 161, no. 9, Jan. 2020, pp. 2107-18, https://doi.org/10.1097/j.pain.0000000000001888.

Wiese, Beth M, et al. “Cannabinoid-2 Agonism With AM2301 Mitigates Morphine-Induced Respiratory Depression.”. Cannabis Cannabinoid Res, Jan. 2020, https://doi.org/10.1089/can.2020.0076.

Levine, Aidan, et al. “DAGLα Inhibition As a Non-Invasive and Translational Model of Episodic Headache.”. Front Pharmacol, vol. 11, Jan. 2020, p. 615028, https://doi.org/10.3389/fphar.2020.615028.

Naseri, Emad, et al. “Development of 3D Printed Drug-Eluting Scaffolds for Preventing Piercing Infection.”. Pharmaceutics, vol. 12, no. 9, Jan. 2020, https://doi.org/10.3390/pharmaceutics12090901.

Mishra, Aarti, et al. “Dynamic Neuroimmune Profile During Mid-Life Aging in the Female Brain and Implications for Alzheimer Risk.”. IScience, vol. 23, no. 12, Jan. 2020, p. 101829, https://doi.org/10.1016/j.isci.2020.101829.

Largent-Milnes, Tally M, et al. “Editorial: Novel Molecular Targets for the Treatment of Pain”. Front Mol Neurosci, vol. 13, Jan. 2020, p. 625714, https://doi.org/10.3389/fnmol.2020.625714.

Liktor-Busa, Erika, et al. “Functional NHE1 Expression Is Critical to Blood Brain Barrier Integrity and Sumatriptan Blood to Brain Uptake.”. PLoS One, vol. 15, no. 5, Jan. 2020, p. e0227463, https://doi.org/10.1371/journal.pone.0227463.

Zhang, Hong, et al. “Glial Neuroimmune Signaling in Opioid Reward.”. Brain Res Bull, vol. 155, Jan. 2020, pp. 102-11, https://doi.org/10.1016/j.brainresbull.2019.11.012.

Liu, Zhigang, et al. “Gut Microbiota Mediates Intermittent-Fasting Alleviation of Diabetes-Induced Cognitive Impairment.”. Nat Commun, vol. 11, no. 1, Jan. 2020, p. 855, https://doi.org/10.1038/s41467-020-14676-4.

Bartlett, Mitchell J, et al. “Highly-Selective µ-Opioid Receptor Antagonism Does Not Block L-DOPA-Induced Dyskinesia in a Rodent Model.”. BMC Res Notes, vol. 13, no. 1, Jan. 2020, p. 149, https://doi.org/10.1186/s13104-020-04994-7.

Duron, David I, et al. “Inhibition of Hsp90 in the Spinal Cord Enhances the Antinociceptive Effects of Morphine by Activating an ERK-RSK Pathway.”. Sci Signal, vol. 13, no. 630, Jan. 2020, https://doi.org/10.1126/scisignal.aaz1854.

Johnston, Bree, and Vanderah, Todd W. “Lost in the Haze: The Physician’s Role in Cannabinoid Prescribing and Advising”. Am J Med, vol. 133, no. 1, Jan. 2020, pp. 7-8, https://doi.org/10.1016/j.amjmed.2019.05.049.

Ellingson, Holly M, and Vanderah, Todd W. “Potential Therapeutic Treatments of Cancer-Induced Bone Pain.”. Curr Opin Support Palliat Care, vol. 14, no. 2, Jan. 2020, pp. 107-11, https://doi.org/10.1097/SPC.0000000000000496.

Wang, Yiwei, et al. “Retrospective Analysis of PhytoSERM for Management of Menopause-Associated Vasomotor Symptoms and Cognitive Decline: A Pilot Study on Pharmacogenomic Effects of Mitochondrial Haplogroup and APOE Genotype on Therapeutic Efficacy.”. Menopause, vol. 27, no. 1, Jan. 2020, pp. 57-65, https://doi.org/10.1097/GME.0000000000001418.

Lochhead, Jeffrey J, et al. “Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders.”. Front Physiol, vol. 11, Jan. 2020, p. 914, https://doi.org/10.3389/fphys.2020.00914.